Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;15(11):3699-3715.
doi: 10.1038/s41596-020-0394-5. Epub 2020 Sep 25.

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

Jianhui Nie #  1 , Qianqian Li #  1   2 , Jiajing Wu #  1   3 , Chenyan Zhao  1 , Huan Hao  1 , Huan Liu  1 , Li Zhang  1 , Lingling Nie  1 , Haiyang Qin  1 , Meng Wang  1 , Qiong Lu  1 , Xiaoyu Li  1 , Qiyu Sun  1 , Junkai Liu  1 , Changfa Fan  4 , Weijin Huang  5 , Miao Xu  6 , Youchun Wang  7   8
Affiliations

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

Jianhui Nie et al. Nat Protoc. 2020 Nov.

Abstract

Pseudotyped viruses are useful virological tools because of their safety and versatility. On the basis of a vesicular stomatitis virus (VSV) pseudotyped virus production system, we developed a pseudotyped virus-based neutralization assay against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in biosafety level 2 facilities. Compared with the binding antibody test, the neutralization assay could discriminate the protective agents from the antibody family. This protocol includes production and titration of the SARS-CoV-2 S pseudotyped virus and the neutralization assay based on it. Various types of samples targeting virus attachment and entry could be evaluated for their potency, including serum samples derived from animals and humans, monoclonal antibodies and fusion inhibitors (peptides or small molecules). If the pseudotyped virus stock has been prepared in advance, it will take 2 days to get the potency data for the candidate samples. Experience in handling cells is needed before implementing this protocol.

PubMed Disclaimer

Comment in

References

    1. Chen, Y. et al. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients. J. Infect. 81, 420–426 (2020). - DOI
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020). - DOI
    1. Chen, Y., Liu, Q. & Guo, D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92, 418–423 (2020). - DOI
    1. Li, C., Yang, Y. & Ren, L. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infect. Genet. Evol. 82, 104285 (2020). - DOI
    1. Wu, A. et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27, 325–328 (2020). - DOI

Publication types

Substances

LinkOut - more resources